As a preliminary attempt to assess whether CRMP2 is relevant for lung carcinoma cell migration, we silenced its expression by transiently transfecting A549 lung carcinoma cells with commercially available CRMP2-specific siRNAs (Figure 1A and Supplementary Figure S1). This evidence concerns the gene DPYSL2 and lung carcinoma.